Home › Non-Muscle Invasive Bladder Cancer › Illinois › Cicero
Non-Muscle Invasive Bladder Cancer clinical trials in Cicero, IL
5 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Loyola University Medical Center, Maywood · 5 mi away
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi away
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge · 10 mi away
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- Associated Urological Specialists, Chicago Ridge · 10 mi away
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 3
- Associated Urological Specialists, Chicago Ridge · 10 mi away
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RecruitingObservational study
- Associated Urological Specialists, Chicago Ridge · 10 mi away
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Philadelphia, PA7 studies
- Birmingham, AL7 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Metastatic Cancer7 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.